Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SELL | P14151 | 1/20 | 0.45 |
| ▸ | SELP | P16109 | 1/20 | 0.45 |
| ▸ | NEU2 | Q9Y3R4 | 3/20 | 0.45 |
| ▸ | NEU4 | Q8WWR8 | 2/20 | 0.45 |
| ▸ | NEU3 | Q9UQ49 | 2/20 | 0.45 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.45 |
| ▸ | MAG | P20916 | 2/20 | 0.41 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15144450 | 0.91 | NANP (0.52) | NANPL3MBTL1SELLSELPNEU2 | |
| Sialic Acid SCHEMBL21049933 | 0.84 | NANP (0.71) | NANPL3MBTL1SELLSELPNEU2 | |
| SCHEMBL23591351 | 0.83 | L3MBTL1 (0.49) | NANPL3MBTL1SELLSELPNEU2 | |
| Sialic Acid SCHEMBL22943658 | 0.82 | NANP (0.72) | NANPL3MBTL1SELLSELPNEU2 | |
| Sialic Acid SCHEMBL22879166 | 0.82 | NANP (0.72) | NANPL3MBTL1SELLSELPNEU2 | |
| Sialic Acid SCHEMBL21067569 | 0.82 | NANP (0.72) | NANPL3MBTL1SELLSELPNEU2 | |
| SCHEMBL23640238 | 0.82 | NANP (0.54) | NANPL3MBTL1SELLSELPNEU2 | |
| Sialic Acid SCHEMBL24274184 | 0.82 | NANP (0.72) | NANPL3MBTL1SELLSELPNEU2 | |
| SCHEMBL23635227 | 0.82 | NANP (0.54) | NANPL3MBTL1SELLSELPNEU2 | |
| Sialic Acid SCHEMBL23366253 | 0.82 | NANP (0.72) | NANPL3MBTL1SELLSELPNEU2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200056222-A1 | Flash and Glow 1,2-Dioxetanes | Life Technologies Corporation | 2020-02-20 | — | — | US | disclosed |
| US-20170321245-A1 | Flash and Glow 1,2-Dioxetanes | Life Technologies Corporation | 2017-11-09 | — | — | US | disclosed |
| WO-2012151142-A2 | FLASH AND GLOW 1,2-DIOXETANES | Life Technologies Corporation (US) | 2012-11-08 | — | — | WO | disclosed |
| WO-2012006351-A1 | IN SITU CHEMILUMINESCENT SUBSTRATES AND ASSAYS | Life Technologies Corporation (US) | 2012-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170321245-A1 | Flash and Glow 1,2-Dioxetanes | GLO1, DDX41, GDA | NANP 1918/4885L3MBTL1 3591/4885SELL 1093/4885 |
| US-20200056222-A1 | Flash and Glow 1,2-Dioxetanes | GLO1, DDX41, GDA | NANP 1918/4885L3MBTL1 3591/4885SELL 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.